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?General ethical aspects 
There are some general aspects to be considered when 
talking about the ethics related to Biotechnology; concerns 
that can be argued to almost all the biotechnological proce-
dures we will discuss later. These ethical aspects are: 
availability and the caution principle (also referred to as the 
slippery-slope principle). 
Availability 
In general, Biotechnology is a high technology field, so 
it is time consuming and expensive, making it available 
only to well developed countries or to economically power-
ful people. These economical implications produce a drift in 
the way Biotechnology evolves, often leaving some inter-
esting research apart due to profitable criteria instead of 
general well-being ones. Such is the case of the research 
on malaria vaccine or the development of transgenic rice 
producing vitamin A precursors (golden rice). Therefore we 
have to be aware that although distributive justice applied 
to Biotechnology is generally accepted, it is not always ex-
erted. 
Caution principle 
Although caution principle could be applied to any new 
technology, it has been especially invoked in Biotechnol-
ogy. 
Caution principle states that no new technology should 
be used (or even developed) until enough guaranties that it 
is harmless are obtained. This principle, although sound, 
can impair scientific progress if applied to its extreme. Most 
technologies have dual aspects and misuse of them to-
wards undue or perverse objectives should not impair their 
development. Emmanuel Kant (1784) already consecrated 
the necessity of scientific improvement in its essay “Answer 
to the Question: What is Enlightenment?” when he wrote 
“An epoch cannot avert or commit itself to put the following 
one in a situation that will be impossible to expand its skills 
(in particular those of maximum urgency), purify them of 
errors and, in general, further progress in the Enlighten-
ment. That would be a crime against human nature, the 
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Resumen 
La Biotecnología, en su sentido más amplio (las tecno-
logías basadas en la biología), es una de las tecnologías 
más notables derivada de los conocimientos de mediados 
del S. XX hasta el S. XXI. En su desarrollo, la biotecnolo-
gía ha ofrecido la posibilidad de mejorar nuestro conoci-
miento de las características más íntimas de un ser vivo, 
es decir, su código genético e incluso, una vez obtenido 
este conocimiento, ir más adelante y modificarlo. La disci-
plina que ha llevado a estas transformaciones es la genéti-
ca y todas las tecnologías basadas en ella. Como mencio-
né, la capacidad de promover el desarrollo de estas tecno-
logías se ejerce primero a través del simple conocimiento 
(información genética) y el segundo a través del cambio 
de las características genéticas de los individuos 
(manipulación genética). Dependiendo de las especies 
involucradas en el proceso biotecnológico, nos referimos a 
esta manipulación como ingeniería genética (cuando se 
aplica a otras especies no humanas) o como terapia géni-
ca (si se aplica a la especie humana). 
Todas estas tecnologías tienen cuestiones éticas que 
deben abordarse, preguntas que han cambiado profunda-
mente el concepto del lugar que ocupa la humanidad en el 
universo, e incluso, el concepto mismo de humanidad. 
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Abstract 
Biotechnology, in its wider sense (technologies based 
on biology), is one of the most striking technologies derived 
from knowledge appearing in the middle XX and early XXI 
century. In its development Biotechnology has offered the 
possibility of improving our knowledge on the most intimate 
characteristics of a living being i.e. its genetic code and 
even, once having this knowledge, going a step forward 
and alter it. The discipline that has prompted these trans-
formations is genetics and all the technologies based on it. 
As mentioned, the capacity to promote the development of 
these technologies is exerted first through the simple 
knowledge (genetic information) and second through 
changing the genetic characteristics of individuals (genetic 
manipulation). Depending on the species involved in the 
biotechnological process we refer to this manipulation as 
genetic engineering (species other than humans) or as 
gene therapy (human species). 
All these technologies have ethical questions to be ad-
dressed, questions that have deeply changed the concept 
of the place humankind occupies in the universe and even 
the concept of humanity itself.  
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original destination of which lies precisely in this pro-
gress ...” meaning that, since present knowledge and tech-
nologies are based on the knowledge developed by prece-
dent generations of scientists while present science be-
comes the groundwork of future knowledge; banning some 
research can cause delays and undesired effects on future 
generations. For instance, transgenic technology or so-
matic cell nuclear transfer (cloning) in humans have 
evolved much more slowly due to this prevention. 
Therefore it seems clear that, although not everything 
that can be done should actually be done, invoking the cau-
tion principle may impair the development of new technolo-
gies that might offer better live conditions to future human 
generations. Seeking a balance between advantages and 
risks (proportionality principle) seems to be the soundest 
approach to this apparent conflict. 
?Genetic information 
Referring to humans, Biotechnology offers the possibil-
ity of developing personalized medicine (pharmacogeno-
mics, toxicogenomics) which provides genetic information 
of the individuals. The use of this information can be done 
by the same individual (self genetic information) or by oth-
ers. 
In general, the ethical aspects of using self genetic in-
formation are envisaged as less relevant because it is as-
sumed that having this information can be regarded as a 
right to be exerted by persons. The main questions to de-
termine are to which extend people have the right to 
achieve this self-knowledge, a knowledge that is expensive 
and difficult to be obtained (at least at present), and who 
should assume the cost of providing this information. Avail-
ability is thus the key point to be addressed in this topic. 
Although knowledge (and especially self knowledge) is 
generally viewed as something positive it can also have 
negative aspects thus arising the right of not knowing. This 
situation appears when the person is at risk of suffering a 
genetic disease for which no cure is available. Under this 
situation, revealing the information without an appropriate 
consent should be considered as ethically unacceptable. 
By contrast, it is generally accepted that the use of per-
sonal genetic information by third parties (other persons, 
companies or institutions) has important ethical and social 
implications. Ethical concerns in this field are mainly de-
rived either from its commercial use (exchanging personal 
genetic data between companies) or from discrimination 
exerted due to this knowledge (for instance people losing 
their jobs because a genetic predisposition to some kind of 
cancers or paying extra fares to insurance companies for 
the same reason). All these preventions are pondered at 
Article 10 on Private life and right to information of the 
Oviedo’s Convention (Council of Europe, Convention on 
Human Rights and Biomedicine, 1997). 
Finally, some people fear that getting genetic informa-
tion specific for some human populations may recover old 
concepts such as human race, thus acting as an intellectual 
support to new forms of racism. 
?Genetic manipulation 
Genetic engineering 
Genetic engineering refers to the modification of the 
genetic characteristics of species other than humans 
(either bacteria, plants or animals; generically referred to 
as GMO -genetically modified organisms- or transgenics) to 
adapt them to the interest of human beings. In fact, it can 
be considered as a sophisticated form of domestication 
having the advantage of being faster and more straightfor-
ward. However, concerns have appeared related to the use 
of this technology. Ethical concerns are mainly related to 
the general aspects already mentioned such as availability 
and, especially, the caution principle. 
While a direct influence of transgenic technologies on 
the human health has been almost discarded, the caution 
principle has been mainly invoked because the threat 
GMOs may represent to environment. Although this is a 
long debate in which scientists and environmentalists argue 
that no direct proves of detrimental effects on nature of 
GMOs have been reported, the contrary (proves on the 
innocuousness of GMOs to environment), seems too still 
be true. Main worries come from reduction on biodiversity 
and substitution of natural organism by uncontrolled GMOs 
which, at the end, may threat other fragile ecosystems. 
Responsibility for leaving a safer world, free from environ-
mental catastrophes to next generations is at the center of 
this debate. 
Transgenics have been proposed to be used either as 
bioreactors, to generate products through biochemical 
pathways in organisms not normally producing them, or to 
act as a source for xenotransplants, by producing organs 
(xenoorgans) in animals susceptible to be transplanted to 
humans. While no especial concerns come up in the first 
aforementioned application, production of xenoorgans do 
arise ethical concerns. Production of chimeras (organism 
having cells from two or more different origins, especially 
from different species) pose ethical preventions, mainly 
when these species are very close. Worries appear when 
the possibility of generating hybrids between human and 
close related species, such as apes, may become true. The 
consideration of this chimeras and even their own self con-
sideration, if they could have any kind of self conscious-
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ness are, without any doubt, one of the most scaring faces 
Biotechnology could offer. 
Recently Biotechnology has moved one step further 
after the report of what has been called synthetic biology, 
which refers to the creation of a completely new organism 
(a bacteria) after designing its whole genetic code. Such an 
approach could be considered at present a sort of “global 
transgenic”, since it has been conceived as a combination 
of different genes coming from different organisms. Claims 
against this possibility have arisen using arguments such 
as scientists playing God or going against the natural order 
of things. Although respectful, all these arguments seem 
not to have a solid scientific groundwork and should be 
maintained in the religious parcel for believers. The playing 
God concern can be considered as a variant of the caution 
principle since supporters of this argument maintain that, 
unlike God, we are not omnipotent and omniscient, thus 
unforeseen and uncontrollable effects may appear when 
developing such technologies. In fact though, the caution 
principle we have already discussed is the main argument 
that can be proposed besides those religious ones. With 
respect to “going against the natural order of things”, 
namely going against natural evolution, this is an argument 
that can be asserted too against any medical intervention 
which converts it as obviously grotesque. 
?Gene therapy 
When genetic manipulation is exerted on human beings 
it is referred to as gene therapy since, in general but not 
exclusively, the main objective of this procedure is to look 
for the remediation of a disease. We will later discuss how 
gene modifications in humans can also be used to improve 
human individuals thus constituting a sort of active eugen-
ics. 
Gene therapy can be employed on cells (cell therapy, 
which includes regenerative medicine) or on embryos. This 
later use derives from the availability of human embryos 
offered by reproductive medicine, a biotechnological proc-
ess with a wide variety of ethical implications to be dis-
cussed. 
Cell therapy – Regenerative medicine 
Cell therapy is based on the use, manipulation and ge-
netic modification of cells. Cell therapy doesn’t have ethical 
implications except when it is performed on a special type 
of cells known as stem cells. These cells are at an undiffer-
entiated state (they are pluripotent) so they can be derived 
into any kind of cells of an organism to regenerate dam-
aged tissues and organs from individuals (regenerative 
medicine). Stem cells can be obtained from adult cells ei-
ther directly (adult stem cells) or by inducing their pluripo-
tentiality (induced Pluripotent Stem Cells -iPS-). The use of 
both type of cells does not present any ethical concern but 
they have some biological characteristics that might make 
them unsuitable for some regenerative processes. By con-
trast, stem cells derived from human spare embryos 
(embryonic stem cells -ESC-) do have the capacity to be 
derived to any kind of cells and seem to be suitable for re-
generative medicine; nevertheless they pose serious ethi-
cal concerns since their production implies embryo destruc-
tion. Worries about their use arise from the consideration a 
human embryo deserves, however we will discuss this topic 
later in the Reproductive medicine section. 
One of the most serious drawbacks that regenerative 
medicine must face is immunological rejection. To solve 
this problem self transplant is proposed which implies the 
use of cells derived from the same adult organism (iPS) or 
the use of cloning technologies to derive genetically identi-
cal ESC, what has been called therapeutic cloning. Cloning 
technology, initially developed for transgenic animal pro-
duction, has been widely criticized because it has been 
considered, according to the slippery-slope principle, an 
open gate to reproductive cloning (which will be later dis-
cussed at the Reproductive medicine section). 
Gene therapy in embryos 
Modification of the genetic characteristics of a whole 
human organism set forth a deep ethical concern: assum-
ing that genetic characteristics are what ultimately defines 
an individual, is it ethically acceptable to modify them thus 
producing a “new individual”? Should we consider such 
procedure a sort of assassination of the old, original indi-
vidual? Moreover, to which extend should we apply this 
technology?; should we use it merely to modify abnormal 
characteristics (merely healing) or should we go one step 
forward and modify some behavioral traits (biological en-
hancement) ? In so far some traits considered valuable to 
offer greater all-round capacities to better living 
(intelligence, memory, self discipline, patience, empathy, 
optimism, etc…) have some genetic basis, genetic manipu-
lation could alter them thus benefiting individuals. Tradition-
ally all these characteristics are modified by environmental 
enhancement (education and cultural refinement); biologi-
cal enhancement could be considered another way to ad-
dress the same objective: increasing people’s chances of 
conducting a better life. According to the beneficence prin-
ciple (all action must be in benefit of individuals) we could 
consider we have a moral obligation to do such. As stated 
by J. Savulescu (2007) “Biological manipulation to increase 
opportunities is ethical. If we have an obligation to treat and 
prevent disease, we have an obligation to try to manipulate 
these characteristics to give an individual the best opportu-
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nity of the best life”. In fact biological enhancement, while 
increasing people’s well-being, could be considered equiva-
lent to treating diseases since health is not only the ab-
sence of pain, but also achieving the maximum well-being. 
However, against biological enhancement it has been 
argued that, as already mentioned, it could be considered 
as altering the identity since it would be altering the genetic 
characteristics of individuals. It could be reasoned this be-
ing true only if significant alterations of mental capacity 
have been performed, but what does “significant altera-
tions” mean? Again, the extend of changes occupies the 
center of the debate. 
Moreover, M. Sandel (2004) proposed that designing 
children leads to master the mystery of birth, alters the pa-
terno-filial relationships and deprive parents of humility by 
banishing the appreciation of life as a gift, leaving them 
with nothing to affirm or behold outside their own will. 
For all these reasons Oviedo’s Convention, in its Article 
13 reads: “An intervention seeking to modify the human 
genome may only be undertaken for preventive, diagnostic 
or therapeutic purposes and only if its aim is not to intro-
duce any modification in the genome of any descendants” 
completely banning gene therapy in embryos. 
The alternative to embryonic genetic manipulation is 
embryo selection using preimplantation genetic diagnosis. 
This is a procedure set for identifying genetically abnormal 
embryos before implantation, aiming at transferring only 
those being normal, while discarding the rest. Since at pre-
sent technology cannot offer a complete screening of the 
whole genome of the embryo, it was initially developed to 
detect abnormal embryos from couples with high risk of 
presenting a determined genetic disease. However it has 
been evolving since it was first developed in 1992 and new 
applications have been proposed: detection of predisposi-
tion for diseases (some forms of breast and colon cancers), 
selecting embryos immunologically compatible with se-
verely ill elder siblings to generate individuals acting as 
donors of cord blood stem cells (called HLA matching), or 
even selecting embryos of the desired sex without any 
medical indication (what is commonly referred to as social 
sexing). 
Complains against preimplantation genetic diagnosis 
have been proposed in the sense that it can be regarded as 
a sort of eugenics. Eugenics is defined as “a science that 
deals with the improvement (as by control of human mat-
ing) of hereditary qualities of a race or breed” (Merriam-
Webster dictionary); however in this case no improvement 
of a human group is pursued but avoiding the birth of a 
children affected by a severe genetic disease. 
Instrumentalization of the embryos and therefore the 
children derived from them is another criticism preimplanta-
tion genetic diagnosis must face, especially addressed to 
HLA matching or social sex procedures. Kantian categori-
cal imperative (Groundwork of the Metaphysic of Morals, 
1785) states that any rational individual can never be used 
merely as a mean to our ends, but always as an end in him 
or herself. This argument can be considered as absolutely 
true for children but may be not for embryos, since preim-
plantation embryos are often not regarded as persons hav-
ing a moral status (see Reproductive medicine section). 
Referring to the children’s instrumentalization it is in fact a 
quite common situation (for instance, children in part being 
conceived to heir a fortune, or to continue a constitutional 
monarchy or simply to solve relationship problems between 
the couple’s members). Therefore, wouldn’t saving an al-
ready existing life (HLA matching) be a “good reason” to 
partially instrumentalize a child? 
Fears on demographic unbalancing of the undesired 
sex, an argument often used against sex selection, seems 
to be excessive when applied to preimplantation diagnosis 
since this is not, and it probably never will be, a widespread 
technology. Moreover, much more dramatic systems to 
exert sex selection, such as selective abortion or even as-
sassination, have been and are still being used. 
The deepest complains appear again when trying to 
decide to which extend these procedures could be used; 
will we accept HLA matching for embryo’s siblings? but, 
what about for cousins or for non family persons? Will we 
accept social sexing only to balance the genres in a family? 
or only if preimplantation diagnosis has been performed for 
medical reasons and during this process the embryo’s sex 
is collaterally obtained? Will it be acceptable if embryos of 
the undesired sex are donated for adoption to couples with 
reproductive problems? Guidelines and law are extremely 
variable in this matter, depending on cultural and religious 
tradition of different countries and societies. 
?Reproductive medicine 
Reproductive medicine makes human embryos avail-
able for the first time in history thus leading to a deep de-
bate on the moral and legal considerations of the human 
embryo. There are two main positions that can be adopted 
on this debate: human embryos should be considered as 
persons from the moment of conception onwards or they 
should be considered as potentially persons but not actual 
persons in such early stages of development. 
The first position is supported by non-reductionist 
(religious) conceptions. According to the Catholic Declara-
tion of the Pontifical Academy for Life “On the basis of a 
complete biological analysis, the living human embryo is - 
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from the moment of the union of the gametes - a human 
subject with a well defined identity, which from that point 
begins its own coordinated, continuous and gradual devel-
opment, such that at no later stage can it be considered as 
a simple mass of cells”. However, hydatidiform moles (a 
kind of abnormal pregnancy that can develop into some 
embryonic cancers), naturally occurring twinning or Sia-
mese phenomena threatens this idea, since none, one, two 
or even something between one and two individuals can be 
derived from the same embryo. Under the first point of view 
a human embryo has a full moral status since it is consid-
ered a person; under the second one it does not have a 
moral status, although it can posses a moral value meaning 
that there are moral reasons to treat it in certain ways and 
not in others. According to the report brought about by NIH 
Human Embryo Research Panel, while the preimplantation 
human embryo “does not have the same moral status as 
infants and children … it deserves special interest and seri-
ous moral consideration as a developing form of human 
life”. This special interest and respect (something similar to 
the respect offered to human remains and corpses) is ex-
pressed by placing restrictions on their use according to 
only morally significant purposes. This later position is the 
one mainly adopted by legislations on human embryo re-
search in most developed countries. 
Another field of debate on the consideration human em-
bryos deserve is the Kantian respect, directly derived from 
the categorical imperative already mentioned. Kantian re-
spect encourages us to treat others (including embryos, it 
could be argued) as ends in themselves. To treat others as 
ends in themselves we must take their ends (their interests, 
projects and goals) seriously and not just our own. It has 
been argued that since embryos do not have interests or 
ends they cannot be considered as ends in themselves, 
therefore Kantian respect cannot be applied to preimplanta-
tion embryos. But which argument supports the idea that 
embryos do not have interests? This idea derives from the 
fact that embryos in such early stages do not have sen-
tience. In this sense B. Steinbock (2007) proposes 
“”Without experiences of any kind,” (preimplantation em-
bryos do not have any nervous cell) “embryos cannot have 
wants. Without wants they cannot have a stake in anything, 
including their health or continued existence…My claim is…
they do not have an interest in being healthy or in continu-
ing to exist”. She adds “Sentience is a condition, not of 
having interests, since temporarily non-sentience beings 
can continue to have interests in the dispositional sense, 
but of acquiring interests”. To have interest in the disposi-
tional sense means to have inherent interest in one’s own 
welfare although not being aware of it. 
The second ethical hot spot of reproductive medicine is 
reproductive cloning. In fact, this is a misleading term since 
clones cannot be considered as the offspring of the original 
individuals but their asynchronous twins, therefore they 
better should be envisaged as siblings. This procedure is 
based on somatic cell nuclear transfer technology devel-
oped to produce transgenic animals which allowed the birth 
of the first mammalian clone, Dolly the sheep, on 1996. 
Although it has not been yet performed in humans or apes, 
and even some authors believe that it will never be possi-
ble to carry it out, it has arisen long and heated debates. 
Human cloning has been proposed to be acceptable 
according to reproductive freedom but has been considered 
as anethical because of many other reasons; being the 
most widely extended that is contrary to human dignity. 
UNESCO’s Universal Declaration on the Human Genome 
and Human Rights in its Article 11 reads: “Practices which 
are contrary to human dignity, such as reproductive cloning 
of human beings, shall not be permitted” and the Oviedo’s 
Convention on the Prohibition of Cloning Human Beings in 
its Preamble reads: “Considering … that the instrumentali-
sation of human beings through the deliberate creation of 
genetically identical human beings is contrary to human 
dignity and thus constitutes a misuse of biology and medi-
cine…”. However, human dignity is a very blur concept that 
is not well defined in both declarations, not clarifying whose 
dignity is threatened by cloning: embryo’s dignity, individu-
als’ to be cloned, individuals’ that perform the cloning proc-
ess, mankind dignity? All these incertitudes make both dec-
larations susceptible of severe counterargumentations 
(Birnbacher, 2005). Another argument against reproductive 
cloning is that it will decrease genetic diversity of human-
kind; this is a true argument but it would have a noticeable 
effect only if it were widely used, which probably will never 
be the case. It also has been argued that it can deprive 
clones from an open future, which is obviously a weak ar-
gument since genetics cannot predetermine a whole human 
life. Finally the only sound and well founded argumentation 
against reproductive cloning is that it yields an extremely 
negative balance between benefits and risks (negative pro-
portionality principle). At present, cloning technology poses 
a serious threat to clone’s health and well-being since 
clones suffer from high spontaneous abortion rates, in-
creased perinatal death rates and fetal malformations; 
moreover, there are no reproductive problems that can be 
solved exclusively by cloning, thus making it useless. Ac-
cording to this, even developing human cloning technolo-
gies would imply a large, unacceptable amount of children 
with severe health problems just to fulfill the odd desire of 
some people. 
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Reproductive medicine is a fast evolving field that is 
constantly raising new ethical concerns ready for debate. 
Recently it has been reported that, in animals, ESC can be 
derived into cells resembling gametes which probably soon 
will have reproductive capacities. This possibility raises two 
new ethical worries. The first one has already been referred 
as ultimate incest because it could offer the possibility of 
self sexual reproduction (which is clearly different from 
cloning) since both male and female gametes might be de-
rived from the same cells. The second one appears if ESC 
are used to produce gametes to solve the shortening of 
gamete donors in most countries: by doing so we would 
allow individuals that have never existed to reproduce; will 
we consider it as ethically acceptable? 
We have done a very quick view over some ethical as-
pects biotechnology has confronted us, but it surely will 
continue to rise new ones as new technologies appear; 
thinking and arguing on them based on true information 
without apriorisms is our duty as democratic and well de-
veloped societies.  
R e v i s t a  d e  B i o é t i c a  y  D e r e c h o  
A r t í c u l o  
http: / /www.bioet icayderecho.ub.es  
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